Search

everythinglearnresearchcommunity

for

Search:↓

The 2006 editorial concluded that immunotherapy was advancing with new drugs, focusing on specific biological therapies and convenient oral treatments, and highlighted the importance of partnerships and new regulations in the field.

Certain natural compounds called terpenes may help prevent prostate cancer.

Enriching the French health care database with external data greatly improved its usefulness.

Nanostructured delivery systems could potentially improve hair loss treatment by targeting drugs to hair follicles, reducing side effects and dosage, but the best size, charge, and materials for these systems need further investigation.

Taking 5-α reductase inhibitors for prostate enlargement or hair loss does not significantly raise the risk of erectile dysfunction.

Afatinib, neratinib, and zanubrutinib could be effective against KRASG12C-mutant tumors.

5-alpha reductase inhibitors increase the risk of sexual dysfunction in patients treating enlarged prostate but not in those treating hair loss.

Dutasteride does not impair mental function in elderly men with enlarged prostate.

Finasteride effectively treats hair loss and enlarged prostate in men, with mild side effects.

Plant-based compounds might be a promising alternative for prostate cancer treatment with fewer side effects.

Triple Hormonal Blockade (ADT3) can effectively manage prostate cancer but requires careful monitoring for heart risks.

Short-term finasteride treatment may lower some cell death factors in prostate cancer cells.

A man got brown patches on his skin (melasma) after taking finasteride, a hair loss treatment.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.

Men who start balding at age 20 may have a higher chance of getting aggressive prostate cancer.

Finasteride may lower cholesterol and slow heart disease progression.

Dutasteride, usually used for prostate issues and hair loss, could potentially treat Amyotrophic Lateral Sclerosis (ALS) due to its neuroprotective, antioxidant, and anti-inflammatory properties, but more testing is needed.

Hair restoration has evolved from surgery to drugs to potential gene therapy, with improved results and ongoing research driven by high demand.

Nanoporous silica entrapped lipid-drug complexes significantly improve the solubility and absorption of drugs that don't dissolve well in water.

Finasteride helps regrow hair and shrink prostate by reducing DHT, with some sexual side effects.

Combining flutamide and finasteride can reduce prostate weight and tumor growth, potentially benefiting treatments needing optimal DHT inhibition.

Long-term use of a drug for hair loss and prostate issues can cause metabolic problems and depression-like behavior in young male rats.

5α-Reductase inhibitors can help treat hair loss, acne, and prostate issues by reducing DHT levels.

Method can accurately measure five BPH drugs at once.

5-alpha-reductase inhibitors can lower prostate cancer risk but may increase high-grade tumors and cause sexual side effects.

Finasteride helps treat hair loss and prostate enlargement by blocking a specific enzyme.

Scientists made new substances that can block an enzyme linked to prostate issues and hair loss, with potential for creating a new treatment.

Flutamide rarely causes liver toxicity in prostate cancer patients.

Tamsulosin works faster, but both drugs have similar effects after 6 months.

New patents show progress in developing drugs targeting the Wnt pathway for diseases like cancer and hair loss.